author-photo

Pavel Svirin

Boston Children's Hospital

20

Papers

186

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

RESULTS OF THE OPEN MULTICENTER PROSPECTIVE CLINICAL STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF MOROCTOCOG ALPHA IN 6 TO 12 YEAR OLD CHILDREN WITH HEMOPHILIA A

2021 Pediatria. Journal named after G.N. Speransky
Show All
- Source
- Cite
- Save
Citations (0)
SPECIFICITY OF THE MOROCTOCOG ALPHA MOLECULE: RESULTS OF A PROSPECTIVE, MULTICENTER, OPEN-LABEL, OBSERVATIONAL STUDY OF EFFICACY AND SAFETY IN CHILDREN AGED 12 TO 18 YEARS WITH HEMOPHILIA A

2021 Pediatria. Journal named after G.N. Speransky
Show All
- Source
- Cite
- Save
Citations (0)
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.

2020 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (14)
Dabigatran Etexilate for the Treatment of Acute Venous Thromboembolism in Children: Results of an Open-Label, Phase 2b/3, Randomised Clinical Trial

2020 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
FEATURES OF CLINICAL STUDIES OF RECOMBINANT COAGULATION FACTORS IХ IN CHILDREN WITH HEMOPHILIA В

2020 Pediatria. Journal named after G.N. Speransky
Show All
- Source
- Cite
- Save
Citations (0)
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

2019 Blood
Show All
- Source
- Cite
- Save
Citations (25)
Prophylactic Treatment with New Recombinant Factor IX Innonafactor (Russia) in Adolescent and Adult Patients with Hemophilia B

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of New Moroctocog Alfa Drug (Octofactor) in Prophylactic Treatment in Adolescent Patients with Severe and Moderate Hemophilia a

2015 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Immune Tolerance Therapy in Children with FVIII Inhibitors

2011 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard–Soulier syndrome

2005 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (38)